placeholder image
L. S. Sy All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Effectiveness of RSV prevention strategies in US infants: 2024-2025. 
    Pediatrics. 2026
  • Influenza activity and estimated vaccine effectiveness during the 2025-2026 influenza season. 
    JAMA network open. 2026
  • Influenza vaccine effectiveness against influenza-associated hospitalizations and emergency department or urgent care encounters among children and adults - United States, 2024-25 season. 
    medRxiv. 2026
  • Influenza vaccine effectiveness against influenza-associated hospitalizations and emergency department or urgent care encounters among children and adults-VISION, United States, 2024-2025 season. 
    Open forum infectious diseases. 2026
  • Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age. 
    Vaccine. 2025
  • Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis. 
    Lancet Reg Health Am. 2025
  • Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States. 
    Clinical Infectious Diseases. 2025
  • Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024. 
    Clinical Infectious Diseases. 2025
  • COVID-19 vaccination coverage and factors associated with vaccine uptake among people with HIV. 
    JAMA network open. 2024
  • Impact of the COVID-19 pandemic on health care utilization in the Vaccine Safety Datalink: retrospective cohort study. 
    JMIR public health and surveillance. 2024
  • Mortality risk after COVID-19 vaccination: a self-controlled case series study. 
    Vaccine. 2024
  • Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. 
    Nature communications. 2024
  • Safety of the seasonal influenza vaccine in 2 successive pregnancies. 
    JAMA network open. 2024
  • A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. 
    Vaccine. 2023
  • Safety of measles, mumps, and rubella vaccine in adolescents and adults in the Vaccine Safety Datalink. 
    Vaccine. 2023
  • Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. 
    Vaccine. 2022
  • Health care utilization in the 6 months following SARS-CoV-2 infection. 
    JAMA network open. 2022
  • Monitoring vaccine safety using the Vaccine Safety Datalink: assessing capacity to integrate data from Immunization Information systems. 
    Vaccine. 2022
  • Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink. 
    Vaccine. 2022
  • Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. 
    Vaccine. 2013
  • Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. 
    Clinical Infectious Diseases. 2013
  • Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink Project. 
    Vaccine. 2013
  • Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. 
    Journal of Internal Medicine. 2012
    • Contact
    full name
  • L. S. Sy
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration